BioRestorative Therapies, Inc. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 33 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $20K | ↓-54.7% | — | — | — |
| 2025-09-30 | $12K | ↓-94.9% | $-3M | ↓-178.4% | -31432.3% |
| 2025-06-30 | $303K | ↑+240.4% | $-3M | ↑+34.1% | -1089.8% |
| 2025-03-31 | $25K | ↓-28.6% | $-5M | ↓-140.2% | -19230.1% |
| 2024-12-31 | $43K | ↑+124.4% | — | — | — |
| 2024-09-30 | $234K | ↑+660.9% | $-1M | ↓-122.9% | -979.0% |
| 2024-06-30 | $89K | ↑+38.1% | $-4M | ↑+29.4% | -2770.8% |
| 2024-03-31 | $35K | ↑+11.8% | $-2M | ↑+69.0% | -11740.7% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$20K
↓-54.7% -$24K YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 63 quarters
margin trajectory tells the operating-leverage storyGross Margin↓-0.6pts
91.7%
Operating Margin↓-30453.3pts
-31432.3%
Net Margin↓-25280.9pts
-25748.1%
Go deeper
BRTX Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyBRTX Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics